Adalimumab Tops Cyclosporine in Preventing Uveitis Relapse

Adalimumab was superior to cyclosporine in preventing uveitis relapse in patients with severe Behçet disease already on corticosteroid therapy, according to randomized, open-label trial results.
Medscape Medical News